Identification of endothelial cell genes expressed in an in vitro model of angiogenesis: induction of ESM-1, (beta)ig-h3, and NrCAM.

Blood vessel growth by angiogenesis plays an essential role in embryonic development, wound healing, and tumor growth. To understand the molecular cues underlying this process we have used the PCR-based subtractive hybridization method, representational difference analysis, to identify genes upregulated in endothelial cells (EC) forming tubes in 3D collagen gels, compared to migrating and proliferating cells in 2D cultures. We identified several previously characterized angiogenic markers, including the alpha(v) chain of the alpha(v)beta3 integrin and plasminogen activator inhibitor-1, suggesting overlap in gene expression between tube-forming cells in vitro and in vivo. We also found a 2- to 10-fold upregulation of (beta)ig-h3 (a collagen-binding extracellular matrix protein), NrCAM (a "neural" cell adhesion molecule), Annexin II (a tPA receptor), ESM-1 (an EC-specific molecule of unknown function), and Id2 (an inhibitory bHLH transcription factor). We identified a novel splice variant of the ESM-1 gene and also detected dramatically enhanced expression of ESM-1 and (beta)ig-h3 in several tumors. Antisense oligonucleotides to (beta)ig-h3 blocked both gene expression and tube formation in vitro, suggesting that (beta)ig-h3 may play a critical role in EC-matrix interactions. These data expand the suite of genes implicated in vascular remodeling and angiogenesis.

[1]  P. Carmeliet,et al.  Angiogenesis in cancer and other diseases , 2000, Nature.

[2]  C. Cintron,et al.  Beta-ig. Molecular cloning and in situ hybridization in corneal tissues. , 1997, Investigative ophthalmology & visual science.

[3]  H. Kleinman,et al.  Inhibitors of basement membrane collagen synthesis prevent endothelial cell alignment in matrigel in vitro and angiogenesis in vivo. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[4]  D. Rifkin,et al.  Plasminogen activators and angiogenesis. , 1996, Current topics in microbiology and immunology.

[5]  G. Yancopoulos,et al.  Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. , 1999, Genes & development.

[6]  P. Carmeliet,et al.  Molecular mechanisms of blood vessel growth. , 2001, Cardiovascular research.

[7]  T. Zderic,et al.  βig-h3, a Transforming Growth Factor–β–Inducible Gene, Is Overexpressed in Atherosclerotic and Restenotic Human Vascular Lesions , 1996 .

[8]  L Orci,et al.  In vitro rapid organization of endothelial cells into capillary-like networks is promoted by collagen matrices , 1983, The Journal of cell biology.

[9]  D. Schatz,et al.  cDNA representational difference analysis: a sensitive and flexible method for identification of differentially expressed genes. , 1999, Methods in enzymology.

[10]  L. Orci,et al.  Leukemia inhibitory factor (LIF) inhibits angiogenesis in vitro. , 1995, Journal of cell science.

[11]  W. Risau,et al.  Mechanisms of angiogenesis , 1997, Nature.

[12]  F. Sablitzky,et al.  Id helix-loop-helix proteins in cell growth and differentiation. , 1998, Trends in cell biology.

[13]  R K Craig,et al.  Methods in molecular medicine. , 1987, British medical journal.

[14]  D. Cheresh,et al.  The role of alphav integrins during angiogenesis: insights into potential mechanisms of action and clinical development. , 1999, The Journal of clinical investigation.

[15]  W. Gerald,et al.  Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts , 1999, Nature.

[16]  M. Presta,et al.  Role of endothelial cell extracellular signal-regulated kinase1/2 in urokinase-type plasminogen activator upregulation and in vitro angiogenesis by fibroblast growth factor-2. , 1999, Journal of cell science.

[17]  S. Kenwrick,et al.  Alternative Splicing of HumanNrCAMin Neural and Nonneural Tissues , 1998, Molecular and Cellular Neuroscience.

[18]  M. Grumet,et al.  Nr-CAM promotes neurite outgrowth from peripheral ganglia by a mechanism involving axonin-1 as a neuronal receptor. , 1999, Developmental biology.

[19]  J. Tavernier,et al.  ESM-1 Is a Novel Human Endothelial Cell-specific Molecule Expressed in Lung and Regulated by Cytokines* , 1996, The Journal of Biological Chemistry.

[20]  R. Jaenisch,et al.  Embryonic lethal mutation in mouse collagen I gene causes rupture of blood vessels and is associated with erythropoietic and mesenchymal cell death , 1984, Cell.

[21]  K. Hajjar,et al.  An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation. , 1994, The Journal of biological chemistry.

[22]  K. Kinzler,et al.  Genes expressed in human tumor endothelium. , 2000, Science.

[23]  Shur-Jen Wang,et al.  The Basic Helix-Loop-Helix Transcription Factor HESR1 Regulates Endothelial Cell Tube Formation* , 2001, The Journal of Biological Chemistry.

[24]  F. Tas,et al.  Angiogenesis and p53 Protein Expression in Breast Cancer: Prognostic Roles and Interrelationships , 2000, American journal of clinical oncology.

[25]  Stanley J. Wiegand,et al.  Vascular-specific growth factors and blood vessel formation , 2000, Nature.

[26]  A. Albini,et al.  c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[27]  B. Jude,et al.  Endocan Is a Novel Chondroitin Sulfate/Dermatan Sulfate Proteoglycan That Promotes Hepatocyte Growth Factor/Scatter Factor Mitogenic Activity* , 2001, The Journal of Biological Chemistry.

[28]  Takeshi Kawamoto,et al.  Characterization of a cartilage-derived 66-kDa protein (RGD-CAP/beta ig-h3) that binds to collagen. , 1997, Biochimica et biophysica acta.

[29]  S. Mahooti,et al.  Distinct signal transduction pathways are utilized during the tube formation and survival phases of in vitro angiogenesis. , 1998, Journal of cell science.

[30]  A. Schor,et al.  Collagen gel assay for angiogenesis : induction of endothelial cell sprouting. , 2001, Methods in molecular medicine.

[31]  J. Madri,et al.  Phenotypic modulation of endothelial cells by transforming growth factor-beta depends upon the composition and organization of the extracellular matrix , 1988, The Journal of cell biology.

[32]  D. Hanahan,et al.  Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.

[33]  T. Kawamoto,et al.  RGD-CAP (βig-h3) enhances the spreading of chondrocytes and fibroblasts via integrin α1β1 , 1999 .

[34]  V. Meignin,et al.  Characterization of the Secreted Form of Endothelial-Cell-Specific Molecule 1 by Specific Monoclonal Antibodies , 2000, Journal of Vascular Research.

[35]  K. Hajjar,et al.  An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. , 1994, The Journal of biological chemistry.

[36]  P. Bates,et al.  Antiproliferative Activity of G-rich Oligonucleotides Correlates with Protein Binding* , 1999, The Journal of Biological Chemistry.

[37]  I. Morita,et al.  Stimulatory effects of insulin and insulin-like growth factor I on migration and tube formation by vascular endothelial cells. , 1992, Atherosclerosis.

[38]  T. Matsumura,et al.  Connective tissue growth factor induces the proliferation, migration, and tube formation of vascular endothelial cells in vitro, and angiogenesis in vivo. , 1999, Journal of biochemistry.

[39]  F. Peale,et al.  Gene expression profiling in an in vitro model of angiogenesis. , 2000, The American journal of pathology.

[40]  C. Pilarsky,et al.  Differential gene expression by endothelial cells in distinct angiogenic states. , 2000, European journal of biochemistry.

[41]  A. Yuan,et al.  Vascular endothelial growth factor 189 mRNA isoform expression specifically correlates with tumor angiogenesis, patient survival, and postoperative relapse in non-small-cell lung cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.